A novel strategy to reveal clinical advantages and molecular mechanism of aidi injection in the treatment of pancreatic cancer based on network meta-analysis and network pharmacology
Open Access
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 285, 114852
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81673829, 82074284)
- Beijing University of Chinese Medicine
This publication has 62 references indexed in Scilit:
- Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic ReviewPLOS ONE, 2011
- Comparative investigations on the protective effects of rhodioside, ciwujianoside‐B and astragaloside IV on radiation injuries of the hematopoietic system in micePhytotherapy Research, 2010
- Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cellsNature Cell Biology, 2010
- AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen speciesBlood, 2010
- IFNα activates dormant haematopoietic stem cells in vivoNature, 2009
- Role of VEGF in organogenesisOrganogenesis, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Unique effects of Stat3 on the early phase of hematopoietic stem cell regenerationBlood, 2006
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000
- Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stromaAnnals of Hematology, 1992